Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
- 28 July 1990
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 336 (8709), 225-229
- https://doi.org/10.1016/0140-6736(90)91745-v
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphismClinical Pharmacology & Therapeutics, 1989
- Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cellsJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- ARE CHILDREN WITH LYMPHOBLASTIC LEUKAEMIA GIVEN ENOUGH 6-MERCAPTOPURINE?The Lancet, 1987
- Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrationsClinical Pharmacology & Therapeutics, 1987
- Oral 6-mercaptopurine in childhood leukemia: Parent drug pharmacokinetics and active metabolite concentrationsClinical Pharmacology & Therapeutics, 1986
- Acute Lymphoblastic Leukemia in ChildhoodPediatric Clinics of North America, 1985
- Childhood leukaemia: a relationship between intracellular 6‐ mercaptopurine metabolites and neutropenia.British Journal of Clinical Pharmacology, 1983
- Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cellsJournal of Pharmacy and Pharmacology, 1983
- Thiopurine methyltransferase biochemical genetics: Human lymphocyte activityBiochemical Genetics, 1982
- Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical propertiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1978